PDGFRB and glioblastoma: Potentiated migration by TNIIIA2 was not influenced by AG1295, a PDGF-R tyrosine kinase inhibitor (Figure 4B), suggesting that the molecular mechanism of TNIIIA2-enhanced GBM cell migration was different from that of TNIIIA2-induced hyper-proliferation in GBM cells.